AJP - Cell Physiology, Vol 264, Issue 3 C687-C693, Copyright © 1993 by American Physiological Society

ARTICLES

Receptor externalization determines sustained contractile responses to endothelin-1 in the rat aorta

R. Marsault, E. Feolde and C. Frelin
Institut de Pharmacologie Moleculaire et Cellulaire, Universite de Nice-Sophia-Antipolis, Valbonne, France.

The role of receptor internalization and recycling in the vasoconstrictor action of endothelin-1 (ET-1) is investigated using a combination of biochemical and physiological experiments. The binding of 125I-ET-1 to cultured aortic myocytes is first defined. Binding is rapidly followed by an internalization of the peptide. Part of the receptor sites then slowly reappears at the cell surface via a cycloheximide-insensitive mechanism. Evidence that externalizing receptors are functional and can trigger contractions is presented. Finally, the actions of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu] (BQ-123), an antagonist of ETA receptors, are investigated. BQ-123 prevents 125I-ET-1 binding to aortic myocytes (dissociation constant, 10 nM). It prevents the constricting action of ET-1 but not that of angiotensin II. BQ-123 also relaxes almost completely aortic strips that have been precontracted by ET-1 irrespective of the time of its addition. It is concluded that a recycling of internalized ET-1 receptors occurs in ET-1-treated aortic myocytes. This process amplifies the action of the peptide and is probably responsible for the unique contractile action of ET-1.

This article has been cited by other articles:

				M. Tosun, Y. Erac, C. Selli, and N. Karakaya Sarcoplasmic-endoplasmic reticulum Ca2+-ATPase inhibition prevents endothelin A receptor antagonism in rat aorta Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1961 - H1966. [Abstract] [Full Text] [PDF]

				C. Bras-Silva, A. P. Fontes-Sousa, C. Moura, J. C. Areias, and A. F. Leite-Moreira Impaired Response to ETB Receptor Stimulation in Heart Failure: Functional Evidence of Endocardial Endothelial Dysfunction? Experimental Biology and Medicine, June 1, 2006; 231(6): 893 - 898. [Abstract] [Full Text] [PDF]

				A. F. Leite-Moreira and C. Bras-Silva Inotropic effects of ETB receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1194 - H1199. [Abstract] [Full Text] [PDF]

				A. Just, A. J. M. Olson, and W. J. Arendshorst Dual constrictor and dilator actions of ETB receptors in the rat renal microcirculation: interactions with ETA receptors Am J Physiol Renal Physiol, April 1, 2004; 286(4): F660 - F668. [Abstract] [Full Text] [PDF]

				A. F. Leite-Moreira, C. Bras-Silva, C. A. Pedrosa, and A. A. Rocha-Sousa ET-1 increases distensibility of acutely loaded myocardium: a novel ETA and Na+/H+ exchanger-mediated effect Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1332 - H1339. [Abstract] [Full Text] [PDF]

				A. P. Gokin, M. U. Fareed, H.-L. Pan, G. Hans, G. R. Strichartz, and G. Davar Local Injection of Endothelin-1 Produces Pain-Like Behavior and Excitation of Nociceptors in Rats J. Neurosci., July 15, 2001; 21(14): 5358 - 5366. [Abstract] [Full Text] [PDF]

				V. Blandin, P. Vigne, J. P. Breittmayer, and C. Frelin Allosteric Inhibition of Endothelin ETA Receptors by 3,5-Dibromosalicylic Acid Mol. Pharmacol., April 13, 2001; 58(6): 1461 - 1469. [Abstract] [Full Text]

				A. Oksche, G. Boese, A. Horstmeyer, J. Furkert, M. Beyermann, M. Bienert, and W. Rosenthal Late Endosomal/Lysosomal Targeting and Lack of Recycling of the Ligand-Occupied Endothelin B Receptor Mol. Pharmacol., June 1, 2000; 57(6): 1104 - 1113. [Abstract] [Full Text]

				A. Talbodec, N. Berkane, V. Blandin, J. P. Breittmayer, E. Ferrari, C. Frelin, and P. Vigne Aspirin and Sodium Salicylate Inhibit Endothelin ETA Receptors by an Allosteric Type of Mechanism Mol. Pharmacol., April 1, 2000; 57(4): 797 - 804. [Abstract] [Full Text]

				E. Tchekneva, M. L. Lawrence, and B. Meyrick Cell-specific differences in ET-1 system in adjacent layers of main pulmonary artery. A new source of ET-1 Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L813 - L821. [Abstract] [Full Text] [PDF]

				C. Wilson, S.-J. Hunt, E. Tang, N. Wright, E. Kelly, S. Palmer, C. Heys, S. Mellor, R. James, and R. Bialecki Pharmacological Profile of ZD1611, a Novel, Orally Active Endothelin ETA Receptor Antagonist J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1085 - 1091. [Abstract] [Full Text]

				A. W. Jones, L. Magliola, C. B. Waters, and L. J. Rubin Endothelin-1 activates phospholipases and channels at similar concentrations in porcine coronary arteries Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1583 - C1591. [Abstract] [Full Text] [PDF]

				R. Hilal-Dandan, S. Villegas, A. Gonzalez, and L. L. Brunton The Quasi-irreversible Nature of Endothelin Binding and G Protein-Linked Signaling in Cardiac Myocytes J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 267 - 273. [Abstract] [Full Text]

				H.-J. Lee, M. Chun, and K. V. Kandror Tip60 and HDAC7 Interact with the Endothelin Receptor A and May Be Involved in Downstream Signaling J. Biol. Chem., May 11, 2001; 276(20): 16597 - 16600. [Abstract] [Full Text] [PDF]

				J. D. Paasche, T. Attramadal, C. Sandberg, H. K. Johansen, and H. Attramadal Mechanisms of Endothelin Receptor Subtype-specific Targeting to Distinct Intracellular Trafficking Pathways J. Biol. Chem., August 31, 2001; 276(36): 34041 - 34050. [Abstract] [Full Text] [PDF]